Fluorine in PDB 3dm6: Beta-Secretase 1 Complexed with Statine-Based Inhibitor
Enzymatic activity of Beta-Secretase 1 Complexed with Statine-Based Inhibitor
All present enzymatic activity of Beta-Secretase 1 Complexed with Statine-Based Inhibitor:
3.4.23.46;
Protein crystallography data
The structure of Beta-Secretase 1 Complexed with Statine-Based Inhibitor, PDB code: 3dm6
was solved by
J.Lindberg,
N.Borkakoti,
S.Nystrom,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
63.76 /
2.60
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
83.435,
103.017,
103.110,
90.00,
103.50,
90.00
|
R / Rfree (%)
|
22.3 /
28.1
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Beta-Secretase 1 Complexed with Statine-Based Inhibitor
(pdb code 3dm6). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Beta-Secretase 1 Complexed with Statine-Based Inhibitor, PDB code: 3dm6:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 3dm6
Go back to
Fluorine Binding Sites List in 3dm6
Fluorine binding site 1 out
of 6 in the Beta-Secretase 1 Complexed with Statine-Based Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Beta-Secretase 1 Complexed with Statine-Based Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1000
b:64.6
occ:1.00
|
F40
|
A:7571000
|
0.0
|
64.6
|
1.0
|
C35
|
A:7571000
|
1.3
|
64.4
|
1.0
|
C34
|
A:7571000
|
2.3
|
64.8
|
1.0
|
C36
|
A:7571000
|
2.4
|
63.6
|
1.0
|
N
|
A:GLY74
|
2.6
|
53.3
|
1.0
|
CD2
|
A:TYR71
|
3.2
|
47.5
|
1.0
|
CB
|
A:TYR71
|
3.2
|
48.0
|
1.0
|
CA
|
A:GLY74
|
3.2
|
52.9
|
1.0
|
O
|
A:GLY74
|
3.2
|
53.5
|
1.0
|
C
|
A:GLY74
|
3.3
|
53.1
|
1.0
|
CG
|
A:TYR71
|
3.4
|
47.4
|
1.0
|
CB
|
A:GLN73
|
3.6
|
53.8
|
1.0
|
C37
|
A:7571000
|
3.6
|
64.7
|
1.0
|
C33
|
A:7571000
|
3.6
|
63.2
|
1.0
|
CD1
|
A:PHE108
|
3.7
|
55.5
|
1.0
|
C
|
A:GLN73
|
3.7
|
54.2
|
1.0
|
CA
|
A:GLN73
|
4.0
|
53.9
|
1.0
|
C38
|
A:7571000
|
4.1
|
63.6
|
1.0
|
N
|
A:LYS75
|
4.1
|
52.8
|
1.0
|
N
|
A:GLN73
|
4.2
|
53.0
|
1.0
|
CE2
|
A:TYR71
|
4.2
|
49.6
|
1.0
|
CE1
|
A:PHE108
|
4.2
|
55.9
|
1.0
|
CA
|
A:TYR71
|
4.4
|
48.7
|
1.0
|
CD1
|
A:TYR71
|
4.6
|
45.1
|
1.0
|
O
|
A:LYS107
|
4.6
|
58.1
|
1.0
|
N
|
A:TYR71
|
4.6
|
47.8
|
1.0
|
CA
|
A:PHE108
|
4.7
|
56.3
|
1.0
|
F39
|
A:7571000
|
4.7
|
65.8
|
1.0
|
O19
|
A:7571000
|
4.7
|
51.0
|
1.0
|
O32
|
A:7571000
|
4.7
|
62.1
|
1.0
|
CG
|
A:PHE108
|
4.7
|
55.9
|
1.0
|
C
|
A:TYR71
|
4.8
|
49.7
|
1.0
|
O
|
A:GLN73
|
4.8
|
56.3
|
1.0
|
CG
|
A:GLN73
|
4.8
|
55.4
|
1.0
|
CB
|
A:PHE108
|
4.9
|
56.1
|
1.0
|
CA
|
A:LYS75
|
5.0
|
52.7
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 3dm6
Go back to
Fluorine Binding Sites List in 3dm6
Fluorine binding site 2 out
of 6 in the Beta-Secretase 1 Complexed with Statine-Based Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Beta-Secretase 1 Complexed with Statine-Based Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1000
b:65.8
occ:1.00
|
F39
|
A:7571000
|
0.0
|
65.8
|
1.0
|
C37
|
A:7571000
|
1.4
|
64.7
|
1.0
|
C36
|
A:7571000
|
2.3
|
63.6
|
1.0
|
C38
|
A:7571000
|
2.4
|
63.6
|
1.0
|
O
|
A:PHE108
|
3.2
|
56.4
|
1.0
|
CD1
|
A:ILE110
|
3.3
|
56.5
|
1.0
|
C35
|
A:7571000
|
3.6
|
64.4
|
1.0
|
C9
|
A:7571000
|
3.7
|
38.7
|
1.0
|
C33
|
A:7571000
|
3.7
|
63.2
|
1.0
|
CZ2
|
A:TRP115
|
3.8
|
50.2
|
1.0
|
CG1
|
A:ILE110
|
3.8
|
57.5
|
1.0
|
CH2
|
A:TRP115
|
3.9
|
50.8
|
1.0
|
C34
|
A:7571000
|
4.1
|
64.8
|
1.0
|
N8
|
A:7571000
|
4.2
|
43.0
|
1.0
|
C
|
A:PHE108
|
4.3
|
56.0
|
1.0
|
C7
|
A:7571000
|
4.4
|
42.0
|
1.0
|
F40
|
A:7571000
|
4.7
|
64.6
|
1.0
|
C10
|
A:7571000
|
4.7
|
45.8
|
1.0
|
CA
|
A:PHE108
|
4.8
|
56.3
|
1.0
|
O32
|
A:7571000
|
4.8
|
62.1
|
1.0
|
O
|
A:LYS107
|
4.9
|
58.1
|
1.0
|
CB
|
A:GLN73
|
5.0
|
53.8
|
1.0
|
CD1
|
A:PHE108
|
5.0
|
55.5
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 3dm6
Go back to
Fluorine Binding Sites List in 3dm6
Fluorine binding site 3 out
of 6 in the Beta-Secretase 1 Complexed with Statine-Based Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Beta-Secretase 1 Complexed with Statine-Based Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1000
b:66.3
occ:1.00
|
F40
|
B:7571000
|
0.0
|
66.3
|
1.0
|
C35
|
B:7571000
|
1.3
|
65.7
|
1.0
|
C36
|
B:7571000
|
2.4
|
64.6
|
1.0
|
C34
|
B:7571000
|
2.4
|
66.2
|
1.0
|
N
|
B:GLY74
|
2.6
|
62.2
|
1.0
|
CA
|
B:GLY74
|
3.3
|
61.4
|
1.0
|
CB
|
B:TYR71
|
3.3
|
57.5
|
1.0
|
O
|
B:GLY74
|
3.3
|
60.3
|
1.0
|
CB
|
B:GLN73
|
3.4
|
62.6
|
1.0
|
CD2
|
B:TYR71
|
3.4
|
57.0
|
1.0
|
C
|
B:GLY74
|
3.4
|
61.0
|
1.0
|
C
|
B:GLN73
|
3.5
|
62.9
|
1.0
|
CG
|
B:TYR71
|
3.6
|
57.2
|
1.0
|
C37
|
B:7571000
|
3.6
|
65.7
|
1.0
|
C33
|
B:7571000
|
3.6
|
64.6
|
1.0
|
CA
|
B:GLN73
|
3.7
|
62.7
|
1.0
|
N
|
B:GLN73
|
3.9
|
62.0
|
1.0
|
CD1
|
B:PHE108
|
4.1
|
64.3
|
1.0
|
C38
|
B:7571000
|
4.1
|
66.0
|
1.0
|
N
|
B:LYS75
|
4.3
|
60.8
|
1.0
|
CE2
|
B:TYR71
|
4.4
|
55.3
|
1.0
|
O
|
B:LYS107
|
4.4
|
69.5
|
1.0
|
O19
|
B:7571000
|
4.4
|
50.2
|
1.0
|
CA
|
B:TYR71
|
4.5
|
58.1
|
1.0
|
CA
|
B:PHE108
|
4.6
|
66.7
|
1.0
|
CG
|
B:GLN73
|
4.7
|
63.7
|
1.0
|
O
|
B:GLN73
|
4.7
|
64.0
|
1.0
|
CD1
|
B:TYR71
|
4.7
|
55.4
|
1.0
|
F39
|
B:7571000
|
4.7
|
67.9
|
1.0
|
CE1
|
B:PHE108
|
4.7
|
63.7
|
1.0
|
O32
|
B:7571000
|
4.8
|
64.7
|
1.0
|
C
|
B:TYR71
|
4.8
|
58.6
|
1.0
|
C18
|
B:7571000
|
4.8
|
52.0
|
1.0
|
N
|
B:TYR71
|
4.9
|
57.7
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 3dm6
Go back to
Fluorine Binding Sites List in 3dm6
Fluorine binding site 4 out
of 6 in the Beta-Secretase 1 Complexed with Statine-Based Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Beta-Secretase 1 Complexed with Statine-Based Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1000
b:67.9
occ:1.00
|
F39
|
B:7571000
|
0.0
|
67.9
|
1.0
|
C37
|
B:7571000
|
1.3
|
65.7
|
1.0
|
C38
|
B:7571000
|
2.3
|
66.0
|
1.0
|
C36
|
B:7571000
|
2.3
|
64.6
|
1.0
|
O
|
B:PHE108
|
3.1
|
66.9
|
1.0
|
CD1
|
B:ILE110
|
3.3
|
68.8
|
1.0
|
CH2
|
B:TRP115
|
3.3
|
59.6
|
1.0
|
CZ2
|
B:TRP115
|
3.4
|
60.4
|
1.0
|
C35
|
B:7571000
|
3.6
|
65.7
|
1.0
|
C33
|
B:7571000
|
3.6
|
64.6
|
1.0
|
CG1
|
B:ILE110
|
3.7
|
67.5
|
1.0
|
C9
|
B:7571000
|
3.7
|
53.2
|
1.0
|
C34
|
B:7571000
|
4.1
|
66.2
|
1.0
|
C
|
B:PHE108
|
4.2
|
66.8
|
1.0
|
N8
|
B:7571000
|
4.3
|
52.5
|
1.0
|
C7
|
B:7571000
|
4.4
|
54.8
|
1.0
|
CZ3
|
B:TRP115
|
4.6
|
58.8
|
1.0
|
F40
|
B:7571000
|
4.7
|
66.3
|
1.0
|
O32
|
B:7571000
|
4.7
|
64.7
|
1.0
|
CE2
|
B:TRP115
|
4.8
|
59.0
|
1.0
|
CA
|
B:PHE108
|
4.8
|
66.7
|
1.0
|
C10
|
B:7571000
|
4.8
|
50.7
|
1.0
|
CD1
|
B:PHE108
|
4.9
|
64.3
|
1.0
|
NE2
|
B:GLN73
|
5.0
|
65.2
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 3dm6
Go back to
Fluorine Binding Sites List in 3dm6
Fluorine binding site 5 out
of 6 in the Beta-Secretase 1 Complexed with Statine-Based Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Beta-Secretase 1 Complexed with Statine-Based Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F1000
b:59.4
occ:1.00
|
F40
|
C:7571000
|
0.0
|
59.4
|
1.0
|
C35
|
C:7571000
|
1.3
|
58.6
|
1.0
|
C36
|
C:7571000
|
2.4
|
57.7
|
1.0
|
C34
|
C:7571000
|
2.4
|
56.9
|
1.0
|
N
|
C:GLY74
|
3.0
|
58.7
|
1.0
|
O
|
C:GLY74
|
3.0
|
56.8
|
1.0
|
C
|
C:GLY74
|
3.2
|
57.5
|
1.0
|
CA
|
C:GLY74
|
3.2
|
57.5
|
1.0
|
CD2
|
C:TYR71
|
3.2
|
51.8
|
1.0
|
CD1
|
C:PHE108
|
3.4
|
54.2
|
1.0
|
CB
|
C:TYR71
|
3.4
|
54.9
|
1.0
|
CG
|
C:TYR71
|
3.5
|
52.8
|
1.0
|
C37
|
C:7571000
|
3.6
|
58.1
|
1.0
|
C33
|
C:7571000
|
3.6
|
55.2
|
1.0
|
C
|
C:GLN73
|
3.8
|
59.5
|
1.0
|
CE1
|
C:PHE108
|
4.0
|
53.4
|
1.0
|
N
|
C:LYS75
|
4.0
|
57.6
|
1.0
|
C38
|
C:7571000
|
4.1
|
57.8
|
1.0
|
CE2
|
C:TYR71
|
4.1
|
51.2
|
1.0
|
CA
|
C:PHE108
|
4.3
|
58.6
|
1.0
|
CG
|
C:PHE108
|
4.4
|
55.8
|
1.0
|
CA
|
C:GLN73
|
4.5
|
59.5
|
1.0
|
N
|
C:GLN73
|
4.5
|
58.8
|
1.0
|
O
|
C:LYS107
|
4.5
|
62.9
|
1.0
|
O
|
C:GLN73
|
4.6
|
60.7
|
1.0
|
CB
|
C:GLN73
|
4.6
|
59.8
|
1.0
|
CB
|
C:PHE108
|
4.6
|
56.9
|
1.0
|
CD1
|
C:TYR71
|
4.6
|
50.6
|
1.0
|
CA
|
C:TYR71
|
4.6
|
55.8
|
1.0
|
F39
|
C:7571000
|
4.7
|
59.0
|
1.0
|
O32
|
C:7571000
|
4.8
|
57.4
|
1.0
|
CA
|
C:LYS75
|
4.8
|
58.3
|
1.0
|
N
|
C:TYR71
|
4.9
|
56.5
|
1.0
|
O
|
C:PHE108
|
4.9
|
58.6
|
1.0
|
O19
|
C:7571000
|
5.0
|
45.5
|
1.0
|
C
|
C:TYR71
|
5.0
|
56.2
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 3dm6
Go back to
Fluorine Binding Sites List in 3dm6
Fluorine binding site 6 out
of 6 in the Beta-Secretase 1 Complexed with Statine-Based Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Beta-Secretase 1 Complexed with Statine-Based Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F1000
b:59.0
occ:1.00
|
F39
|
C:7571000
|
0.0
|
59.0
|
1.0
|
C37
|
C:7571000
|
1.3
|
58.1
|
1.0
|
C36
|
C:7571000
|
2.3
|
57.7
|
1.0
|
C38
|
C:7571000
|
2.4
|
57.8
|
1.0
|
CD1
|
C:ILE110
|
3.0
|
57.4
|
1.0
|
O
|
C:PHE108
|
3.3
|
58.6
|
1.0
|
C35
|
C:7571000
|
3.6
|
58.6
|
1.0
|
C33
|
C:7571000
|
3.6
|
55.2
|
1.0
|
CZ2
|
C:TRP115
|
3.7
|
49.2
|
1.0
|
C9
|
C:7571000
|
3.8
|
38.6
|
1.0
|
CH2
|
C:TRP115
|
3.9
|
50.0
|
1.0
|
NE2
|
C:GLN73
|
3.9
|
65.3
|
1.0
|
CG1
|
C:ILE110
|
3.9
|
57.0
|
1.0
|
N8
|
C:7571000
|
4.0
|
45.6
|
1.0
|
C34
|
C:7571000
|
4.1
|
56.9
|
1.0
|
C7
|
C:7571000
|
4.3
|
42.6
|
1.0
|
C
|
C:PHE108
|
4.4
|
58.1
|
1.0
|
C10
|
C:7571000
|
4.6
|
46.0
|
1.0
|
F40
|
C:7571000
|
4.7
|
59.4
|
1.0
|
O32
|
C:7571000
|
4.7
|
57.4
|
1.0
|
|
Reference:
M.Back,
J.Nyhlen,
I.Kvarnstrom,
S.Appelgren,
N.Borkakoti,
K.Jansson,
J.Lindberg,
S.Nystrom,
A.Hallberg,
S.Rosenquist,
B.Samuelsson.
Design, Synthesis and Sar of Potent Statine-Based Bace-1 Inhibitors: Exploration of P1 Phenoxy and Benzyloxy Residues Bioorg.Med.Chem. V. 16 9471 2008.
ISSN: ISSN 0968-0896
PubMed: 18842420
DOI: 10.1016/J.BMC.2008.09.041
Page generated: Wed Jul 31 18:00:26 2024
|